Akbulut S, Sahin TT, Yilmaz S. Comment on pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality. World J Gastroenterol 2020; 26(30): 4564-4566 [PMID: 32874065 DOI: 10.3748/wjg.v26.i30.4564]
Corresponding Author of This Article
Sami Akbulut, MD, Associate Professor, Deaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Elazig Yolu 10. Km, Malatya 44280, Turkey. akbulutsami@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter To The Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 14, 2020; 26(30): 4564-4566 Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4564
Comment on pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality
Sami Akbulut, Tevfik Tolga Sahin, Sezai Yilmaz
Sami Akbulut, Tevfik Tolga Sahin, Sezai Yilmaz, Deaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey
Author contributions: Akbulut S and Sahin TT designed and performed the research, and analyzed the data; Akbulut S and Sahin TT wrote the letter; Yilmaz S and Akbulut S revised the letter.
Conflict-of-interest statement: All other authors have nothing to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Sami Akbulut, MD, Associate Professor, Deaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Elazig Yolu 10. Km, Malatya 44280, Turkey. akbulutsami@gmail.com
Received: May 7, 2020 Peer-review started: May 7, 2020 First decision: May 15, 2020 Revised: May 19, 2020 Accepted: August 4, 2020 Article in press: August 4, 2020 Published online: August 14, 2020 Processing time: 97 Days and 23 Hours
Abstract
Since the first successful liver transplantation was performed five decades ago, pediatric liver transplantation has become the gold standard treatment choice for pediatric liver disease, including metabolic diseases, liver tumors, and some acute liver failure. With improvements in immunosuppression, surgical techniques, and postoperative medical care, long-term outcomes of patients after liver transplantation have markedly improved, especially in pediatric patients.
Core tip: With improvements in immunosuppression, surgical techniques, and postoperative medical care, long-term outcomes of patients after liver transplantation have markedly improved, especially in pediatric patients. We read with great interest the recent article “Pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality” published by Pan and colleagues. We would like to share our opinion and criticisms about this valuable work.
